看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | No | Yes |
Is net profit margin increasing? | No | Yes |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Shanghai HeartCare Medical Technology Corporation Limited |
LifeTech Scientific Corporation |
Angelalign Technology Inc. |
Acotec Scientific Holdings Limited |
Xiangyu Medical Co.,Ltd |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
6,609 | 1,302 | 6,699 | 6,669 | 688,626 | 9,996 | |||
Return On Equity | ||||||||
Latest Twelve Months | -4% | 7% | 1% | 2% | 5% | -11% | ||
Fiscal Year - 1 | -16% | 12% | 6% | 6% | 11% | -14% | ||
Fiscal Year - 2 | -19% | 12% | 15% | -17% | 6% | -20% | ||
Fiscal Year - 3 | -56% | 12% | 38% | 36% | 15% | -183% | ||
Fiscal Year - 4 | NA | 11% | 30% | 62% | 30% | 163% | ||
Fiscal Year - 5 | NA | 11% | 36% | NA | 27% | NA | ||
Average | -24% | 11% | 21% | 18% | 16% | -13% | ||
Median | -17% | 11% | 22% | 6% | 13% | -14% | ||
Benchmarks | Ticker | |||||||
Shanghai HeartCare Medical Technology Corporation Limited | SEHK:6609 | |||||||
LifeTech Scientific Corporation | SEHK:1302 | |||||||
Angelalign Technology Inc. | SEHK:6699 | |||||||
Acotec Scientific Holdings Limited | SEHK:6669 | |||||||
Xiangyu Medical Co.,Ltd | SHSE:688626 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | Feb-18 | Jul-03 | May-18 | Apr-18 | May-85 | May-27 | ||
Latest Fiscal Year | Dec-23 | Dec-23 | Dec-23 | Dec-23 | Dec-24 | Dec-23 | ||
LTM Period | Jun-24 | Jun-24 | Jun-24 | Jun-24 | Dec-24 | Jun-24 | ||
Revenues | ||||||||
Latest Twelve Months | 251 | 1,281 | 1,721 | 523 | 744 | 517 | ||
Fiscal Year | 232 | 1,267 | 1,476 | 474 | 744 | 441 | ||
Fiscal Year - 1 | 183 | 1,097 | 1,270 | 396 | 745 | 251 | ||
Fiscal Year - 2 | 90 | 925 | 1,272 | 304 | 489 | 137 | ||
Fiscal Year - 3 | 15 | 642 | 817 | 194 | 523 | 39 | ||
Fiscal Year - 4 | NA | 669 | 646 | 125 | 496 | 19 | ||
Fiscal Year - 5 | NA | 557 | 488 | NA | 427 | NA | ||
Net Income | ||||||||
Latest Twelve Months | (45) | 249 | 44 | 32 | 103 | (252) | ||
Fiscal Year | (94) | 263 | 53 | 14 | 103 | (393) | ||
Fiscal Year - 1 | (200) | 325 | 214 | 70 | 227 | (408) | ||
Fiscal Year - 2 | (194) | 292 | 286 | (79) | 125 | (574) | ||
Fiscal Year - 3 | (214) | 216 | 151 | (44) | 202 | (2,069) | ||
Fiscal Year - 4 | (75) | 129 | 69 | 23 | 196 | (532) | ||
Fiscal Year - 5 | NA | 121 | 60 | NA | 129 | (83) | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 1,250 | 4,082 | 4,689 | 1,605 | 2,592 | 2,829 | ||
Latest Fiscal Quarter | 1,196 | 4,820 | 5,094 | 1,709 | NA | 2,614 | ||
Fiscal Year | 1,201 | 4,696 | 4,757 | 1,611 | NA | 2,672 | ||
Fiscal Year - 1 | 1,313 | 3,690 | 4,486 | 1,411 | 2,592 | 3,316 | ||
Fiscal Year - 2 | 1,505 | 3,184 | 4,141 | 1,307 | 2,368 | 3,164 | ||
Fiscal Year - 3 | 774 | 2,955 | 1,210 | 273 | 2,183 | 2,881 | ||
Fiscal Year - 4 | 91 | 1,772 | 853 | 112 | 982 | 879 | ||
Fiscal Year - 5 | NA | 1,531 | 473 | NA | 724 | 174 | ||
Fiscal Year - 6 | NA | 1,270 | NA | NA | 561 | NA | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 1,118 | 3,243 | 3,359 | 1,305 | 2,091 | 2,445 | ||
Latest Fiscal Quarter | 1,070 | 3,422 | 3,232 | 1,337 | 2,026 | 2,181 | ||
Fiscal Year | 1,076 | 3,370 | 3,340 | 1,297 | 2,026 | 2,274 | ||
Fiscal Year - 1 | 1,165 | 2,900 | 3,607 | 1,276 | 2,091 | 2,638 | ||
Fiscal Year - 2 | 1,373 | 2,504 | 3,319 | 1,207 | 1,928 | 3,019 | ||
Fiscal Year - 3 | 681 | 2,340 | 502 | (281) | 1,935 | 2,813 | ||
Fiscal Year - 4 | 81 | 1,152 | 297 | 37 | 744 | (558) | ||
Fiscal Year - 5 | NA | 1,240 | 167 | NA | 547 | (94) | ||
Fiscal Year - 6 | NA | 1,053 | NA | NA | 415 | NA |